Table 1.
Factors impacting the choice of TAVR over iSAVR.
| TAVR < 75 Years n = 104 | |
|---|---|
| Prohibitive surgical risk, n (%) 1 | 8 (7.7) |
| Porcelain aorta, n (%) 1 | 9 (8.7) |
| High-risk reoperation, n (%) | 42 (40.4) |
| Respiratory impairment, n (%) | 41 (39.4) |
| Severely reduced LVEF, n (%) | 34 (32.7) |
| Severe renal insufficiency, n (%) | 32 (30.8) |
| Substance abuse, n (%) | 23 (22.1) |
| Adipositas per magna, n (%) | 16 (15.4) |
| Valve-in-Valve procedure, n (%) | 13 (12.5) |
| Neurological impairment, n (%) | 12 (11.5) |
| Hepatopathy, n (%) | 10 (9.6) |
| History of radiation to the chest, n (%) | 9 (8.7) |
| Severe mental disorder, n (%) | 9 (8.7) |
| Pulmonary hypertension, n (%) | 7 (6.7) |
| Frailty, n (%) | 3 (2.9) |
| Severe rhythm disorder, n (%) | 2 (1.9) |
| History of severe bleeding, n (%) | 1 (1.0) |
| Other, n (%) | 17 (16.3) |
| Patients with 2 or more reasons listed above | 74 (71.2) |
| Patients with 3 or more reasons listed above | 35 (33.7) |
1 Excluded from analysis due to absolute SAVR contraindications; LVEF—left ventricular ejection fraction; iSAVR—isolated surgical aortic valve replacement; TAVR—transcatheter aortic valve replacement.